Your leading voice in digital health news
Twitter X Logo

First-in-human trial of cholesterol-lowering genetic therapy to begin at Victorian Heart Hospital

22 May 2026
By Pulse+IT
The first-in-human clinical trial of a new investigational genetic therapy that aims to lower cholesterol in people at increased risk of cardiovascular disease will take place at the Victorian Heart Hospital and the Victorian Heart Institute. The Victorian Heart Hospital, operated by Monash Health in partnership with Monash University, will be the first clinical trial […]

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down